03 · Intelligence
Six unoccupied or underserved opportunities in the OTC category. Eight key brands mapped by therapeutic focus, innovation posture, and competitive move. Updated May 2026.
Methodology: Our analysis cross-references regulatory sources, trade data, and consumer signals to track ingredient and format momentum across the relevant market segments. Regulatory findings draw on FDA, FTC, and professional body primary sources. Trade and market data draw on industry press and published market research. Consumer and search signals inform velocity assessments.
Opportunities identified through gap analysis across the four OTC segments. Prioritised by addressable market size, timing, and formulation difficulty.
Eight key OTC brands mapped by segment focus, recent strategic moves, and competitive positioning. Intelligence directional — based on public data.
| Brand / company | Segment focus | Recent strategic move | Positioning | Competitive signal |
|---|
This white space analysis and competitive map are prepared for a select audience of brand, investor, and advisory clients. Submit your details — Brendan will follow up directly.
Unlocking full intelligence now. Brendan will be in touch shortly.
Already have access? Contact Brendan directly.